Emisphere Technologies, Inc. (OTCBB:EMIS) and Alchemia Ltd. (ASX:ACL) announced that they are joining efforts to develop an oral formulation of the anti-coagulant drug fondaparinux with Emisphere's Eligen® Technology. Emisphere's broad-based drug delivery platform, known as the Eligen®...